Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The role of the tumor microenvironment in drug resistance in multiple myeloma

Lawrence Boise, PhD, Winship Cancer Institute of Emory University, Atlanta, GA, briefly discusses how the tumor microenvironment plays a role in resistance to targeted therapies in multiple myeloma. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.